4[4]Stary HC,Chandler AB,Glagov S,et al.A definition of initial,fatty streak,and intermediate lesions of atherosclerosis.A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis,American Heart Association[J].Circulation,1994,89:2462-2478.
5[5]Nilsson J.Cytokines and smooth muscle cells in atherosclerosis[J].Cardiovasc Res,1993,27:1184-1190.
6[6]Kim CJ,Khoo JC,Gillotte-Taylor K,et al.Polymerase chain reaction-based method for quantifying recruitment of monocytes to mouse atherosclerotic lesions in vivo:enhancement by tumor necrosis factorα and interleukin1 beta[J].Arterioscler Thromb Vasc Biol,2000,20:1976-1982.
7[7]Hynes RO,Wagner DD.Genetic manipulation of vascular adhesion molecules in mice[J].J Clin Invest,1996,98:2193-2195.
8[8]Schillinger M,Exner M,Mlekusch W,et al.Inflammation and Carotid Artery--Risk for Atherosclerosis Study (ICARAS)[J].Circulation,2005,111:2203-2209.
9[9]Nighoghossian N,Derex L,Douek P.The vulnerable carotid artery plaque:current imaging methods and new perspectives[J].Stroke,2005,36:2764-2772.
10[10]Corvol JC,Bouzamondo A,Sirol M,et al.Differential effects of lipid-lowering therapies on stroke prevention:a mcta-analysis of randomized trials[J].Arch Intern Med,2003,163:669-676.
